Cancer Policy: Pharmaceutical Safety

Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chap...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: McKoy, June M. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), West, Dennis P. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
Έκδοση:1st ed. 2019.
Σειρά:Cancer Treatment and Research, 171
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Pharmacovigilance programs: Do they improve Cancer Drug Safety?
  • Impact of Cost on the Safety of Cancer pharmaceuticals
  • Assessing pharmaceutical safety in Geriatric Oncology
  • Cancer co-Morbidity: Implications for Drug Safety
  • Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions?
  • Pharmacovigilance of alternative medications in the Cancer Setting
  • Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology
  • Biosimilars: Are they really safe?
  • Natural Language processing: improving the identification and communication of Cancer Drug Safety
  • The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety
  • Anatomy of Risk Evaluation and Mitigation Strategies (REMS)
  • Cancer Drug Toxicity: Moving from patient to Survivor.